Gilead rolls out Stribild pill in U.K., Germany; Ireland adopts reference pricing, generics incentives;

@FiercePharma: More Indian hospitals eye anti-Ranbaxy policies, Business Standard reports. Some patients asking to switch. Report | Follow @FiercePharma

@EricPFierce: U.S. arrests 2 Pakistani men for selling controlled substances via the Internet. Interpol tracks them to London. Story | Follow @EricPFierce

@CarlyHFierce: First Ranbaxy, now Wockhardt - what is India to do about its manufacturing problems? Regulators unsure. More | Follow @CarlyHFierce

> Armed with a new approval from European regulators, Gilead Sciences ($GILD) launched its combination HIV pill Stribild in the U.K. and Germany, with Austria, Italy, Spain and the Nordic countries coming soon. Report

> Irish lawmakers passed legislation to introduce reference pricing for drugs and to incentivize use of cheap generics; the measure is expected to take effect next month. Report

> Bayer said U.S. antitrust regulators approved its $1.1 billion acquisition of the contraceptive devices company Conceptus. Report

> Hong Kong's Zuellig Group is selling its Australian pharma wholesaler Symbion to the drug and animal health products company Ebos and will in turn take a 40% stake in the New Zealand company. Report

> India's Cipla posted disappointing results for its fiscal fourth quarter, with sales up 2.4% and net profits down 8%. Report

Medical Device News

@FierceMedDev: Luminex re-ups assay deal with Merck KGaA. News | Follow @FierceMedDev

@DamianFierce: Cyberonics slides after CMS again rejects depression device for reimbursement. Article | Follow @DamianFierce

> Teleflex snags CE mark for balloon catheter. More

> CMS declines coverage for Cyberonics' depression device. Story

> Biosensors bets on 15% annual growth thanks to M&A. Article

> Toshiba, TPG said to bid on Panasonic's billion-dollar health biz. Report

Biotech News

@FierceBiotech: GSK buys Okairos (Fierce 15 profile) for $325M, strengthens vaccines biz. Release | Follow @FierceBiotech

@JohnCFierce: Novo spearheads $175M financing to back Ophthotech's PhIII AMD study. News | Follow @JohnCFierce

@RyanMFierce: UPDATED: GlaxoSmithKline bags genetic vaccine developer Okairos for $325M. Article | Follow @RyanMFierce

@EmilyMFierce: University of Alabama begins Parkinson's biomarker study. Story | Follow @EmilyMFierce

> Alexandria lands anchor R&D tenant for San Francisco biotech cluster. Article

> GenVec seeks liquidation after gene therapy setbacks. Report

> Novo spearheads $175M financing to back Ophthotech's PhIII AMD study. More

> Sights set on Asia, Amgen sets up JV development deal with Astellas. News

Biomarkers News

> New CTC technology looks promising to track evolution of prostate cancer. Report

> Swedish team discovers protein common to aggressive bladder cancer. More

> Cenix to collaborate with Debiopharm on predictive biomarkers. Article

> Pancreatitis or cancer? Mayo Clinic says mutated gene points the way. Story

> Johns Hopkins: Two genes help predict postpartum depression risk. Item

Drug Delivery News

@MichaelGFierce: Morphine delivery platform could diminish abuse potential. Item | Follow @MichaelGFierce

> Shape-shifting nanoparticles anchor to tumor cells, deliver drugs. Story

> New drug targets lock-and-key mechanism of prostate cancer growth. Article

> Covidien completes successful drug-coated balloon trial. More

> Inhalable chemo-carrying nanoparticles target lung cancer directly. Report

And Finally... The fight against malaria in Africa has been hobbled by an influx of phony drugs. Report